These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28164635)

  • 1. MicroRNA-122 as a Novel Non-Invasive Marker of Liver Fibrosis in Hepatitis C Virus Patients.
    Omran AA; Osman KS; Kamel HM; Abdel-Naem EA; Hasan DE
    Clin Lab; 2016 Jul; 62(7):1329-1337. PubMed ID: 28164635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
    Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patients.
    Andrés-Otero MJ; De-Blas-Giral I; Puente-Lanzarote JJ; Serrano-Aulló T; Morandeira MJ; Lorente S; Lou-Bonafonte JM
    Clin Biochem; 2016 May; 49(7-8):560-5. PubMed ID: 26968102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
    Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
    Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
    Cordie A; Salama A; El-Sharkawy M; El-Nahaas SM; Khairy M; Elsharkawy A; Hassany M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1106-1111. PubMed ID: 29476628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C.
    Güzelbulut F; Çetınkaya ZA; Sezıklı M; Yaşar B; Ozkara S; Övünç AO
    Turk J Gastroenterol; 2011 Jun; 22(3):279-85. PubMed ID: 21805418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
    Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
    Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
    Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
    Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?
    Resino S; Bellón JM; Asensio C; Micheloud D; Miralles P; Vargas A; Catalán P; López JC; Alvarez E; Cosin J; Lorente R; Muñoz-Fernández MA; Berenguer J
    BMC Infect Dis; 2010 Aug; 10():244. PubMed ID: 20723207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C.
    Pokorska-Śpiewak M; Kowalik-Mikołajewska B; Aniszewska M; Pluta M; Marczyńska M
    BMC Infect Dis; 2017 May; 17(1):361. PubMed ID: 28535787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
    Loko MA; Castera L; Dabis F; Le Bail B; Winnock M; Coureau G; Bioulac-Sage P; de Ledinghen V; Neau D;
    Am J Gastroenterol; 2008 Aug; 103(8):1973-80. PubMed ID: 18796094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C.
    Maieron A; Salzl P; Peck-Radosavljevic M; Trauner M; Hametner S; Schöfl R; Ferenci P; Ferlitsch M
    Aliment Pharmacol Ther; 2014 Feb; 39(3):331-8. PubMed ID: 24308724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non invasive assessment of liver fibrosis in chronic hemodialysis patients with viral hepatitis C.
    Arrayhani M; Sqalli T; Tazi N; El Youbi R; Chaouch S; Aqodad N; Ibrahimi SA
    Pan Afr Med J; 2015; 22():273. PubMed ID: 26958136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
    Shaker OG; Senousy MA
    J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study.
    Said M; Soliman Z; Daebes H; M El-Nahaas S; El-Serafy M
    Expert Rev Gastroenterol Hepatol; 2019 Dec; 13(12):1189-1195. PubMed ID: 31702417
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect serum fibrosis markers in hepatitis C virus (HCV) infection.
    Paunovic K; Stojanovic M; Dimitrijevic Z; Paunovic G; Djordjevic V; Konstantinovic L; Kostic S
    Med Arch; 2012; 66(4):226-30. PubMed ID: 22919875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.